One Equity Partners (OEP), the global private equity investment arm of JP Morgan Chase & Co, has bought a controlling stake in China Medicine Corporation for US$69.6 million. The purchase was made through OEP’s wholly-owned affiliate, OEP CHME Holdings.
The full version of this story is available at www.chinalawandpractice.com.